维普期刊资源整合服务平台（V6.5）

42篇 您的检索式：作者名="GRIESSHAMMER M"

选中清除导出查看参考文献查看引证文献引用追踪共3页首页上一页第1页下一页末页 /3 跳转

	题名	作者	年代	出处	被引量
1	Throm-bopoietin serum levels in patients with aplastic anaemia:correlation with platelet count and persistent elevation in remission显示文摘	Schrezenmeier H Griesshammer M Hornkohl A	1998	Br J Haematol1998，100，3：	1
2	Ruxolitinib versus standard therapy for the treatment of polycythemia vera 显示文摘	Vannucchi AM Kiladjian JJ Griesshammer M	2015	N Eng J Med2015，372，2：	1
3	The V617Fmutation in JAK2 is associated with poorer survival in idiopathic myeloibrosis显示文摘	Campbell PJ Griesshammer M Dghner K	2006	Blood2006，107，：	1
4	V617F mutationin JAK2 is associated with poorer survival inidiopathie myelofibrosis 显示文摘	Campbell PJ Griesshammer M Dohner K	2005	Blood2005，107，5：	1
5	Chronic myelogenous leukemia in blast crisis: retrospective analysis of prognostic factor in 90 patients显示文摘	Griesshammer M Heinze B Hellmann A	1996	Ann hematol1996，73，5：	1
6	Ruxolitinib versus standard therapy for the treatment of polycythemia vera 显示文摘	Vannucchi AM Kiladjian JJ Griesshammer M	2015	N Engl J Med2015，372，5：	1
7	Ruxolitinb versus standard therapy for the treatment of Polycythemia vera 显示文摘	Vannucchi A Kiladjian JJ Griesshammer M	2015	N Engl J Med2015，372，5：	1
8	Essential thrombocythemia and pregnancy显示文摘	Griesshammer M Heimpel H Pearson TC	1996	Leuk Lymphoma1996，22，1：	1
9	Thromobopoietin ,serum levels in patients with aplastic anaemia: Correlation with platelet count and persistant elevation in remission显示文摘	Schrezenmeior H Griesshammer M Homkohl A	1998	Br J Haematol1998，100，：	1
10	Pregnancy and renal failure-the case for application of dosage guidelines 显示文摘	Keller F Griesshammer M Haussler U	2001	Drugs2001，61，13：	1
11	V617F mutationin JAK2 is associated with poorer survival in idiopathic myelofi-brosis显示文摘	Campbell PJ Griesshammer M Dohner K	2006	Blood2006，107，5：	1
12	Increased platelet surface expression of p - selectin and thrombospondin as markers of platelet activation in essential thrombocythaemia 显示文摘	GRIESSHAMMER M BENEKE H NUSSBAUMEER B	1999	Thrombosis Res1999，2，：	1
13	Ruxolitinib versus standard therapy for the treatment of polycythemia vera 显示文摘	Epub ahead of print Vannucchi AM Kiladjian JJ Griesshammer M	2015	N Engl J Med2015，372，5：	1
14	Increased plateletsurface expression of P-selectin and thrombospondin as markers of platelet activation in essential thrombocythaemia显示文摘	Griesshammer M Beneke H Nussbauer B	1999	Thromb Res1999，96，2：	1
15	A multicenter phase-Ib/II study of ruxolitinib/pomalidomide combination therapy in patients with primary and secondary myelofibrosis:safety data from the Mpnsg-0212 trial (NCT01644110)显示文摘	STEGELMANN F GRIESSHAMMER M RE1TER A	2014	Blood2014，124，21：	1
16	Ruxolitinib versus standard therapy for the treatment of polycythemia vera显示文摘	Vannucchi AM Kiladjian JJ Griesshammer M	2015	N Engl J Med2015，372，5：	1
17	Thrombopoietin serum levels in patients with aplastic anemia:correlation with platelet count and persistent elevation in remission显示文摘	Griesshammer M Hornkohl A	1998	Br J Haematol1998，，：	1
18	Ruxolitinibproves superior to best available therapy in a prospective,randomized, phase 3 study (RESPONSE ) in patients withpolycythemia vera resistant to or intolerant of hydroxyurea 显示文摘	Vannucchi AM Kiladjian JJ Griesshammer M	2014	19thCongress of the European Hematology Association ( EHA)2014，39，8：	1
19	Increased platelet surface expression of p-selection and thrombespondin as markers of platelet avtviation in essential thrombocythaemia 显示文摘	Griesshammer M Beneke H Nussbaumer B	1999	Thrombosis Res1999，46，2：	1
20	Thrombopoietin serum levels in patients with aplastic anaemia:correlation with platelet count and persistent elevation in remission显示文摘	Schrezenmeier H Griesshammer M Hornkohl A	1998	Br J Haematol1998，100，3：	1

返回顶部每页显示：

共3页首页上一页第1页下一页末页 /3 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示